ammonium hydroxide has been researched along with Bipolar Disorder in 11 studies
azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Excerpt | Relevance | Reference |
---|---|---|
"These findings suggest that carnitine deficiency is associated with the VPA dose and the serum VPA level in patients with bipolar disorder." | 7.96 | Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder. ( Ishioka, M; Kubo, K; Miyazaki, K; Nakagami, T; Shimoda, K; Sugawara, N; Tarakita, N; Yasui-Furukori, N; Yokoyama, S, 2020) |
"Valproic acid, a branched short-chain fatty acid, has numerous action mechanisms which turn it into a broad spectrum anticonvulsant drug and make its use possible in some other pathologies such as bipolar disorder." | 7.80 | Hyperammonemia associated with valproic acid concentrations. ( Alvariza, S; Fagiolino, P; Guevara, N; Ibarra, M; Magallanes, L; Maldonado, C; Olano, I; Olmos, I; Vázquez, M, 2014) |
"We describe a patient with lithium-induced nephrogenic diabetes insipidus in whom detailed investigations of distal tubular function were performed." | 7.66 | Lithium-induced nephrogenic diabetes insipidus: studies of tubular function and pathogenesis. ( Alroy, GG; Better, OS; Chaimovitz, C; Rapoport, J, 1979) |
" Three groups of patients were studied: (A) epileptic under phenytoin monotherapy (n = 31); (B) with bipolar disorder under valproic acid treatment (n = 28); (C) elderly (n = 41)." | 5.22 | Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia. ( Fagiolino, P; González, R; Guevara, N; Maldonado, C; Queijo, C; Vázquez, M, 2016) |
"These findings suggest that carnitine deficiency is associated with the VPA dose and the serum VPA level in patients with bipolar disorder." | 3.96 | Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder. ( Ishioka, M; Kubo, K; Miyazaki, K; Nakagami, T; Shimoda, K; Sugawara, N; Tarakita, N; Yasui-Furukori, N; Yokoyama, S, 2020) |
"Valproic acid, a branched short-chain fatty acid, has numerous action mechanisms which turn it into a broad spectrum anticonvulsant drug and make its use possible in some other pathologies such as bipolar disorder." | 3.80 | Hyperammonemia associated with valproic acid concentrations. ( Alvariza, S; Fagiolino, P; Guevara, N; Ibarra, M; Magallanes, L; Maldonado, C; Olano, I; Olmos, I; Vázquez, M, 2014) |
"We describe a patient with lithium-induced nephrogenic diabetes insipidus in whom detailed investigations of distal tubular function were performed." | 3.66 | Lithium-induced nephrogenic diabetes insipidus: studies of tubular function and pathogenesis. ( Alroy, GG; Better, OS; Chaimovitz, C; Rapoport, J, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Yokoyama, S | 1 |
Yasui-Furukori, N | 1 |
Nakagami, T | 1 |
Miyazaki, K | 1 |
Ishioka, M | 1 |
Tarakita, N | 1 |
Kubo, K | 1 |
Sugawara, N | 1 |
Shimoda, K | 1 |
Kopel, J | 1 |
Grooms, A | 1 |
Ganapathy, V | 1 |
Clothier, J | 1 |
Vázquez, M | 2 |
Fagiolino, P | 2 |
Maldonado, C | 2 |
Olmos, I | 1 |
Ibarra, M | 1 |
Alvariza, S | 1 |
Guevara, N | 2 |
Magallanes, L | 1 |
Olano, I | 1 |
Queijo, C | 1 |
González, R | 1 |
Wagner, KD | 1 |
Redden, L | 1 |
Kowatch, RA | 1 |
Wilens, TE | 1 |
Segal, S | 1 |
Chang, K | 1 |
Wozniak, P | 1 |
Vigna, NV | 1 |
Abi-Saab, W | 1 |
Saltarelli, M | 1 |
BARUK, H | 1 |
Raby, WN | 1 |
Panikkar, GP | 1 |
Gilman, SM | 1 |
Rapoport, J | 1 |
Chaimovitz, C | 1 |
Alroy, GG | 1 |
Better, OS | 1 |
Rivelli, M | 1 |
el-Mallakh, RS | 1 |
Nelson, WH | 1 |
Capalna, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Depakote ER for the Treatment of Bipolar Disorder in Children and Adolescents[NCT00067262] | Phase 3 | 150 participants | Interventional | 2003-03-31 | Completed | ||
An Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents[NCT00195767] | Phase 3 | 150 participants | Interventional | 2004-07-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for ammonium hydroxide and Bipolar Disorder
Article | Year |
---|---|
Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.
Topics: Acetylcarnitine; Adolescent; Adult; Aged; Aged, 80 and over; Ammonia; Bipolar Disorder; Carnitine; E | 2016 |
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Ammonia; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Child; Delayed-Action | 2009 |
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Ammonia; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Child; Delayed-Action | 2009 |
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Ammonia; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Child; Delayed-Action | 2009 |
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Ammonia; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Child; Delayed-Action | 2009 |
9 other studies available for ammonium hydroxide and Bipolar Disorder
Article | Year |
---|---|
Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
Topics: Ammonia; Anticonvulsants; Bipolar Disorder; Carnitine; Epilepsy; Female; Humans; Male; Middle Aged; | 2020 |
Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.
Topics: Adult; Amino Acid Substitution; Ammonia; Animals; Anticonvulsants; Autistic Disorder; Bipolar Disord | 2021 |
Hyperammonemia associated with valproic acid concentrations.
Topics: Adolescent; Adult; Ammonia; Bipolar Disorder; Carnitine; Child; Dietary Supplements; Dose-Response R | 2014 |
[RECENT RESEARCH ON BILIARY CATATONINE, ELECTROPHORETIC DISORDERS OF THE SERUM AND AMMONIA EXCESS IN BLOOD IN CATATONIA AND SEVERAL PERIODIC PSYCHOSES].
Topics: Ammonia; Bile; Bipolar Disorder; Blood; Blood Protein Electrophoresis; Blood Sedimentation; Catatoni | 1963 |
Carnitine for valproic acid-induced hyperammonemia.
Topics: Adult; Ammonia; Bipolar Disorder; Carbamoyl-Phosphate Synthase (Ammonia); Carnitine; Depressive Diso | 1997 |
Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.
Topics: Adult; Ammonia; Anticonvulsants; Bipolar Disorder; Humans; Male; Mental Disorders; Middle Aged; Psyc | 1999 |
Lithium-induced nephrogenic diabetes insipidus: studies of tubular function and pathogenesis.
Topics: Ammonia; Bipolar Disorder; Diabetes Insipidus; Electrolytes; Female; Glomerular Filtration Rate; Hum | 1979 |
Carbamazepine-associated asterixis and hyperammonemia.
Topics: Adult; Ammonia; Bipolar Disorder; Carbamazepine; Humans; Male; Movement Disorders; Posture | 1988 |
Exploration of the bodily functions and functional disorders of the endogenous depressions.
Topics: Acetylcholine; Adenine Nucleotides; Amino Acids; Ammonia; Bipolar Disorder; Brain; Carbon Dioxide; D | 1968 |